CNBC Investing Club Reveals Top and Bottom Performers During SixWeek Market Rally Microsoft and Anthropic in Talks for Custom AI Chip Deal Following 5 Billion Investment Trump Organization Tbilisi Project Raises ConflictofInterest Concerns Over Sanctioned Ties SP 500 Earnings Growth Broadens Underdogs Outside Big Tech Drive Fastest Profit Expansion in Nearly 5 Years Micron Technology Surges as UBS Triples Price Target on AI Demand Nears 1 Trillion Valuation Amazon Faces Allegations of Profiting from NowIllegal Policy EPAM Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Amid Cautious Outlook PLX Q1 2026 Earnings Major EPS Beat Driven by Strong Operational Performance GDS Holdings Q1 2026 Earnings Stunning EPS Beat of 132 vs Expected Loss Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises GPGI Q1 2026 Earnings EPS Misses Estimates by 535 Stock Declines RMBI Q1 2026 Earnings Solid EPS Performance Amid Quiet Quarter Maxeon Solar Technologies MAXN Holds Steady at 076 Amid Key Technical Levels Weave Communications WEAV Treads Lower as Support Levels Come into Focus Gaming and Leisure Properties GLPI Edges Lower Amidst RangeBound Trading NeoVolta Inc Warrant NEOVW Holds at 122 as Traders Eye Key Levels Solid Power Inc Warrant SLDPW Surges 29 as Warrants Catch Up with Underlying Stock SpaceX IPO Could Catapult Elon Musk to Trillionaire Status and Create MultibillionDollar Windfalls for Employees and Investors SoftBank Group Surges 20 as AI Momentum Gains Steam Following Nvidia Earnings Report Dow Jones Futures Edge Higher as SP 500 and Nasdaq Hit New Highs Earnings Movers Include Zscaler Modine Semtech AI Economy Reshapes Labor Demand ATT CEO Highlights BlueCollar Worker Shortage Prediction Markets Signal Growing Odds of Fed Rate Hike by July 2027 AnheuserBusch InBev Shares Dip as Quarterly Sales Fall Short of Analyst Expectations Oil Prices Surge Past 100 a Barrel as Market Faces Potential Point of No Return PED Q1 2026 Earnings Strong EPS Beat Highlights Operational Progress GT Biopharma Inc GTBP Falls Over 10 as Biotech Sentiment Weakens